Social Leverage Acquisition Cor
SLAC-WT News Today: Stay Updated with the Latest Social Leverage Acquisition Cor News in Real Time
Find SLAC-WT news now at Meyka AI. Stay informed with the latest Social Leverage Acquisition Cor stocks updates, including price news, market analysis, and expert insights.

Earnings due 13 Mar 2026: GBM Resources (GBZ.AX ASX) pre-market view, cash focus
GBZ.AX stock: post-earnings pre-market check on cash, production outlook and Meyka AI forecast

1788.HK Stock Today: ICAC-SFC Raids Probe Insider Trading – March 12
Guotai Junan International falls after ICAC-SFC raids tied to an IPO placements probe. We cover price action, compliance risks, key levels, and what HK investors should watch next.

+13.66% intraday to €4.66: ALSAS.PA Stradim (EURONEXT) 12 Mar 2026, volume rising
Intraday update on ALSAS.PA stock: +13.66% to €4.66 with rising relative volume on EURONEXT

157,000-share spike on close: Monitor 3738.T T-Gaia Corp JPX 12 Mar 2026
Volume spike highlights 3738.T stock on JPX with **157,000.00** shares; Meyka AI 12-month target JPY **3,200.00**

8489.HK drops 18% to HK$0.27 on 12 Mar 2026 Market closed: monitor liquidity
Market closed: 8489.HK stock fell 18% to HK$0.265 on 12 Mar 2026; high volume and weak EPS raise valuation risks

MGG.DE MGM Resorts (XETRA) up 10.37% to €36.29 intraday: volume surge signals momentum
MGG.DE stock jumps to €36.29 intraday on heavy volume; quick Meyka AI forecast, grade and outlook

FECHF Fidelity China Special Situations PLC (PNK) $3.49 12 Mar 2026: Volume watch
FECHF stock trades at $3.49 on 12 Mar 2026; high-volume mover during market hours with valuation and volume signals

INFY.NS stock at INR 1265.80 on 12 Mar 2026: AI demand supports outlook
INFY.NS stock analysis: price INR 1265.80, PE 18.04, Meyka AI forecast and outlook

Nemetschek SE (NEMA.SW) up 8.52% to CHF62.40 on SIX intraday 12 Mar 2026: earnings due 19 Mar may test momentum
NEMA.SW stock rises 8.52% to CHF62.40 intraday on SIX; watch earnings 19 Mar and Meyka AI forecast for a -8.88% 12-month outlook